Gut bacteria and body response in liver disease
Part of Digestive system clinical trials.
This study looks at the bacteria in your gut (microbiome) and how your body responds to liver disease. Researchers want to learn if these factors can help improve care for people with liver problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosed liver disease, confirmed by your doctor.
- You are between 18 and 70 years old.
- You can understand English well enough to read or talk about the study.
- You have not taken antibiotics, steroids, or immune-suppressing drugs in the last month.
- You are not pregnant or breastfeeding.
- You do not have other active gut diseases like Crohn's, colitis, or irritable bowel syndrome.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving a mixture of helpful bacteria can improve gut health in people hospitalized with serious liver problems. It aims to see if restoring these bacteria can help with recovery.
This study looks at how the gut microbiome affects treatment response in patients with advanced liver cancer who are receiving immunotherapy. It involves a colonoscopy to collect samples and may help improve future treatments.
This study looks at the bacteria in the gut of people with HIV or hepatitis B. You may be asked to provide a stool sample to help researchers understand how these infections affect your microbiome.
This study looks at the bacteria naturally living in your gut (the microbiome) to better understand liver cirrhosis. It does not test a new drug or treatment, only collects information and samples.
This study looks at how gut bacteria differ in people with specific liver diseases and their household contacts. It may help researchers understand the connection between the liver and gut.
This study looks at how lactate-related changes in gut bacteria might affect the progression of liver cirrhosis. It includes both healthy people and cirrhosis patients to see how these factors relate.
Hear when a new Gut Microbiome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.